Wellness in the modulator era: An observational study of the impact of CFTR modulator therapy on the well-being of people with cystic fibrosis
Journal of Cystic Fibrosis · 2025-07 · 24 (4) · 642-651
DOI: 10.1016/j.jcf.2024.06.010 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Cystic Fibrosis, 2025-07. Verfasst von Aricca D Van Citters und 15 weiteren Autor:innen. Beteiligte Einrichtung: The Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine at Dartmouth, Level 5 WTRB, One Medical Center Drive, Lebano…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Quality of Life, Cystic Fibrosis Transmembrane Conductance Regulator, Chloride Channel Agonists. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cystic Fibrosis Foundation.
Abstract (Originalsprache)
BACKGROUND: People with cystic fibrosis (PwCF) have experienced substantial improvements in health following use of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies. However, less is known about how modulator therapies impact well-being. METHODS: We used a cross-sectional observational study to identify relationships between CFTR modulator therapies, health-related quality of life (HRQoL), and well-being. Adult PwCF and caregivers of children with CF completed the Wellness in the Modulator Era (Well-ME) survey between June 22 and July 31, 2022. HRQoL was measured with PROMIS Global 10/Global 7 + 2 Parent Proxy. We used a mixed methods analysis to compare experiences and concerns of PwCF who currently (n = 665), no longer (n = 51), or never (n = 184) took modulator therapy. RESULTS: Adult PwCF taking a modulator (n = 416) reported better PROMIS global physical health than those who no longer (n = 37) or never took a modulator (n = 94) and better PROMIS global mental health than those who never took a modulator. Caregiver-reported HRQoL was similar across children with CF who currently, no longer, or never took a modulator. PwCF taking a modulator reported larger improvements in physical health, quality of life, social well-being, and treatment burden than those who no longer or never took a modulator. Nearly one-quarter (23 %) of PwCF taking modulator therapy reported worsening of mental well-being. CONCLUSIONS: This study expands our knowledge of well-being among PwCF in the CFTR modulator era as reported by patients and parents. Findings lay the groundwork for establishing future research priorities, policy efforts, and communications in areas that improve well-being for PwCF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine at Dartmouth, Level 5 WTRB, One Medical Center Drive, Lebanon, NH, USA. Electronic address: Aricca.D.Van.Citters@Dartmouth.edu.
- Cystic Fibrosis Foundation, 4550 Montgomery Avenue, Suite 1100N, Bethesda, MD, USA.
- Division of Endocrinology, Lipids, and Metabolism, Department of Medicine, Emory University, 101 Woodruff Cr NE, Atlanta, GA 30322, USA.
- Indiana University School of Medicine, Division of Pulmonary, Critical Care, Occupational and Sleep Medicine, 1120W. Michigan St, Indianapolis, IN 46202, USA.
- Community Advisor to the Cystic Fibrosis Foundation, Bethesda, MD, USA.
- Department of Medicine, Jacobs School of Medicine and Biomedical Sciences of the University of Buffalo, 1001 Main Street, Conventus Building, 4th floor, Buffalo, NY 14023, USA.
Förderung
- Cystic Fibrosis Foundation
Zitieren
APA
Van Citters, A. D., Aliaj, E., Alvarez, J. A., Brown, C. D., Cary, J., Cravens, R., Frederick, C. A., Georgiopoulos, A. M., Goss, C. H., Kazmerski, T. M., King, J. R., Lawrence, M., Lovell, C., Roman, C., Tillman, L., & Yu, E. (2025). Wellness in the modulator era: An observational study of the impact of CFTR modulator therapy on the well-being of people with cystic fibrosis. Journal of Cystic Fibrosis, 24(4), 642-651. https://doi.org/10.1016/j.jcf.2024.06.010
Vancouver
Van Citters AD, Aliaj E, Alvarez JA, Brown CD, Cary J, Cravens R, et al. Wellness in the modulator era: An observational study of the impact of CFTR modulator therapy on the well-being of people with cystic fibrosis. Journal of Cystic Fibrosis. 2025;24(4):642-651. doi:10.1016/j.jcf.2024.06.010
BibTeX
@article{VanCitters2025,
author = {Van Citters, Aricca D and Aliaj, Enid and Alvarez, Jessica A and Brown, Cynthia D and Cary, Jamie and Cravens, Rachel and Frederick, Carla A and Georgiopoulos, Anna M and Goss, Christopher H and Kazmerski, Traci M and King, Joel R and Lawrence, Melanie and Lovell, Caitlyn and Roman, Christina and Tillman, Laura and Yu, Elizabeth},
title = {Wellness in the modulator era: An observational study of the impact of CFTR modulator therapy on the well-being of people with cystic fibrosis},
journal = {Journal of Cystic Fibrosis},
year = {2025},
volume = {24},
number = {4},
pages = {642--651},
doi = {10.1016/j.jcf.2024.06.010}
}
EUVIMED